Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Written by MarketBeat Staff
May 18, 2023

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
3.6885 of 5 stars		$20.46-5.3%N/AN/AModerate Buy$35.85
Ultragenyx Pharmaceutical (RARE)
3.4079 of 5 stars		$14.88-4.7%N/AN/AHold$34.58
Sarepta Therapeutics (SRPT)
3.6606 of 5 stars		$18.95-8.9%N/AN/AHold$24.07
Pfizer (PFE)
2.7919 of 5 stars		$28.160.8%6.11%37.06Hold$28.39
Exelixis (EXEL)
2.3428 of 5 stars		$56.73-2.4%N/A17.84Hold$50.29
Moderna (MRNA)
1.9838 of 5 stars		$182.11-0.2%N/AN/AHold$76.72
United Therapeutics (UTHR)
4.2829 of 5 stars		$489.42-1.6%N/A17.51Moderate Buy$646.00
Biogen (BIIB)
2.7284 of 5 stars		$227.531.0%N/A40.27Moderate Buy$230.14
Sanofi (SNY)
3.5212 of 5 stars		$41.66-2.0%4.22%21.81Hold$49.50
Eli Lilly and Company (LLY)
4.8223 of 5 stars		$1,153.69-1.4%0.60%38.71Moderate Buy$1,305.25
Compare These Stocks
Discuss with ChatGPT
Add These Stocks to My Watchlist

Featured Articles and Offers

Micron, Coherent and Tower Semiconductor: 3 Stocks Built on AI's Bottlenecks
NVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In It
By Bridget Bennett | September 20, 2026
tc pixel
Trump's New Dollar
Trump's New Dollar
From Porter & Company (Ad)
An oil tanker anchored near a port terminal with storage tanks and hills visible in the background.
The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
By Thomas Hughes | September 17, 2026
Aeluma logo displayed over a semiconductor wafer on a fabrication tool, representing a chipmaking company.
Aeluma’s Selloff Could Be Setting Up Its Next Big Move
By Thomas Hughes | September 17, 2026
IonQ logo displayed against a dark background with glowing orange network nodes and geometric shapes.
IonQ and NVIDIA Just Cracked a Major Quantum Computing Bottleneck
By Jeffrey Neal Johnson | September 17, 2026
tc pixel
$0. Later: $29.97.
$0. Later: $29.97.
From Profits Run (Ad)
Enterprise Products, Energy Transfer and Williams: 3 AI Power Bottleneck Plays
The AI Bottleneck Is Not Chips Anymore and 3 Pipeline Stocks Are Cashing In
By Bridget Bennett | September 20, 2026
Bloom Energy fuel cell units installed outside a data center building labeled "AI" at dusk.
Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?
By Thomas Hughes | September 21, 2026
Interest Rates Can‘t Touch These 3 Stocks (One is Up 540%)
Interest Rates Can't Touch These 3 Stocks (One is Up 540%)
MarketBeat TV |
Watch Video

Recent Videos

Trump Is Betting Billions on These Stocks (You‘ll Regret Following)
Trump Is Betting Billions on These Stocks (You'll Regret Following)
MarketBeat TV |
Watch Video
These Stocks Almost Died... Now They‘re Up 130% (UNTHINKABLE Comeback)
These Stocks Almost Died... Now They're Up 130% (UNTHINKABLE Comeback)
MarketBeat TV |
Watch Video
History Is About to Be Made (Stocks Are Roaring Back)
History Is About to Be Made (Stocks Are Roaring Back)
MarketBeat TV |
Watch Video

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines